Sonova Holding (OTCMKTS:SONVY) Given Average Recommendation of "Reduce" by Analysts

Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) have received a consensus recommendation of "Reduce" from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating and four have given a hold rating to the company.

A number of analysts have recently commented on the stock. HSBC lowered shares of Sonova from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Hsbc Global Res lowered shares of Sonova from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Kepler Capital Markets raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. BNP Paribas lowered shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research report on Wednesday, June 11th. Finally, Barclays lowered shares of Sonova from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th.

Sonova Stock Performance

SONVY traded up $0.36 during trading on Friday, reaching $57.58. The company had a trading volume of 247,538 shares, compared to its average volume of 21,350. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. Sonova has a 12 month low of $52.83 and a 12 month high of $77.56. The business's fifty day moving average price is $61.75 and its 200 day moving average price is $62.56.

Sonova Increases Dividend

The company also recently announced a dividend, which was paid on Wednesday, July 2nd. Investors of record on Tuesday, June 17th were issued a dividend of $0.6243 per share. This represents a yield of 0.99%. This is an increase from Sonova's previous dividend of $0.57. The ex-dividend date was Monday, June 16th.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.